- Home
- FDUS vs ORGO Comparison
FDUS vs ORGO Comparison
Compare FDUS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDUS | ORGO |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 719.4M | 732.3M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDUS | ORGO |
|---|---|---|
| Price | $19.68 | $4.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $21.50 | $8.00 |
| AVG Volume (30 Days) | 373.1K | ★ 1.5M |
| Earning Date | 11-06-2025 | 02-26-2026 |
| Dividend Yield | ★ 11.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | $151,176,000.00 | ★ $465,218,000.00 |
| Revenue This Year | $6.61 | $8.14 |
| Revenue Next Year | $4.08 | $6.33 |
| P/E Ratio | $8.18 | ★ N/A |
| Revenue Growth | ★ 4.25 | 2.24 |
| 52 Week Low | $16.70 | $2.61 |
| 52 Week High | $23.55 | $7.08 |
Technical Indicators
Market Signals| Indicator | FDUS | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 52.93 | 33.18 |
| Support Level | $19.17 | $4.24 |
| Resistance Level | $19.86 | $4.40 |
| Average True Range (ATR) | 0.37 | 0.27 |
| MACD | 0.06 | -0.14 |
| Stochastic Oscillator | 86.13 | 2.95 |
Price Performance
Historical ComparisonAbout FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.